Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Pulmonary Embolism × apixaban × Clear all

Phase

Phase 3 3 Phase NA 2 Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thrombosis 1 Thromboembolism 1 Thrombocytopenia 1 Pulmonary Embolism 1

Interventions

perflutren 1 apixaban 1 Sulfur Hexafluoride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡